Abstract: Provided is a sensing device and a method for fabricating the same. The sensing device includes a first sensor including a first substrate, first electrodes, and a first passivation layer and a second sensor disposed on the first sensor and including a second substrate, second electrodes, and a second passivation layer. The second sensor is connected to the first sensor through a chemical bonding.

Abstract: The present disclosure relates to: an adipocyte-targeting non-viral gene delivery complex comprising a sh(FABP4+FABP5) dual plasmid vector; and treatment for obesity and obesity-induced metabolic syndromes by using the same and, more particularly, to a gene delivery complex comprising: an adipocyte-targeting sequence; a nine-arginine (R9) peptide; and a dual plasmid vector comprising a gene for treatment of obesity and obesity-induced metabolic syndromes, wherein the gene for treatment of obesity and obesity-induced metabolic syndromes is a base sequence inhibiting the expression of a FABP4 gene and a FABP5 gene. According to the present disclosure, in order to treat obesity-related diseases, a dual plasmid vector capable of simultaneously inhibiting the FABP4 and FABP5 genes is produced, and this vector is bound to a predetermined delivery system that specifically delivers the vector into adipocytes so as to provide a gene delivery complex.

Abstract: A control device of a compressor includes a piston which reciprocates by a swash plate, a crankcase receiving the swash plate mounted such that an inclination angle thereof is variable, a discharge chamber from which a compressed working fluid is discharged, a suction chamber sucking the working fluid to be compressed, a first communication channel connecting the suction chamber and the crankcase, a second communication channel connecting the discharge chamber and the crankcase, and a control valve which selectively opens and closes the first communication channel and the second communication channel. The control device includes a suction pressure sensor measuring a pressure of the suction chamber, a valve control unit determining a target suction pressure on the basis of the value measured by the suction pressure sensor and a set temperature, and a valve driving unit controlling the opening degree of the control valve to achieve the target suction pressure.

Abstract: The present invention relates to a visceral adipose tissue macrophage-targeted non-viral gene/carrier complex for preventing and treating obesity-induced type II diabetes. More specifically, the gene/carrier complex according to the present invention delivers a therapeutic gene in a stable manner in a case of being injected into the body with the visceral adipose tissue macrophages being targeted, and thus exhibits an excellent inhibitory effect against TACE, which allows the gene/carrier complex to be applied for prevention or treatment of obesity-induced type II diabetes.

Abstract: A compressor control module (CCM) controls an output of a variable displacement swash plate compressor. The CCM directly calculates, or receives from an external source, a signal indicating a desired or required output from the compressor, receives a current value of the desired or required output, and receives or calculates a current rotation speed and angle, with respect to a rotation axis, of a swash plate, or a current piston stroke length and a reciprocating frequency of the compressor. The CCM determines a difference between the desired or required output from the compressor and the current value and outputs a signal to a valve driving unit which will adjust an angle of a swash plate such that the actual value becomes closer to, or the same as, the desired or required output, taking into account the additional values received or calculated in the receives or calculates step.

Abstract: A compressor having a front housing in which a crank chamber is formed. A cylinder block is coupled to an opposite surface facing the front housing and includes reciprocating pistons in a plurality of cylinder bores. A rear housing is coupled to an opposite surface facing the cylinder block, the rear housing includes a suction chamber and a discharge chamber formed therein. A rotating shaft 400 is inserted via centers of the front housing and the cylinder block, the shaft inserted into a swash plate. A diameter maintenance part is configured to constantly maintain a diameter based on an axis direction of the piston 220. A sensor part is configured to sense a speed and a stroke of the piston in accordance with a change in position of a position determination part positioned on one side of the diameter maintenance part.

Abstract: A variable displacement reciprocating piston unit includes a sensor probe, a target, a piston having a top dead center position and a bottom dead center position, and a signal processing unit. The sensor probe, the target, and the piston are located in relation to each other so that the target is moved from being absent from the sensor probe to being present at the sensor probe when the piston travels towards the top dead center position, and the target is moved from being present at the sensor probe to being absent from the sensor probe when the piston travels towards the bottom dead center position. The signal processing unit generates a signal indicating a stroke speed and a stroke length of the piston from a signal from the sensor probe indicating a presence and/or an absence of the target as the target moves relative to the sensor probe.

Abstract: Provided is a sensing device and a method for fabricating the same. The sensing device includes a first sensor including a first substrate, first electrodes, and a first passivation layer and a second sensor disposed on the first sensor and including a second substrate, second electrodes, and a second passivation layer. The second sensor is connected to the first sensor through a chemical bonding.

Abstract: Disclosed is a gene/carrier complex for preventing or treating inflammatory diseases, including tumor necrosis factor-? converting enzyme (TNF-? converting enzyme, TACE) shRNA and a nonviral gene carrier, wherein the nonviral gene carrier includes an acetate of disulfide-linked poly(oligo-arginine) or a TFA salt of poly(oligo-aspartic acid)poly(oligo-arginine).

Abstract: The present invention relates to a method for differentiating hair follicle cells into germline stem cells, germline stem cells differentiated by the method, and use of the same germline stem cells. A method of differentiating hair follicle cells into germline stem cells according to the present invention can differentiate hair follicle cells into germline stem cells using culture conditions only, without genetic modification. Capable of inducing differentiation of cells of specific individual types, such as hair follicle cells, into cells of different types such as germline cells, the present invention is therefore expected to be usefully used for the understanding of reproductive biology and the clinical application thereof.

Abstract: Disclosed herein a method of determining the type of human body in a thermo-therapeutic apparatus. In the method of determining the type of human body in a thermo-therapeutic apparatus, a control unit scans the entire spine of a user by moving a moxibustion device using a horizontal motor, measures the operating current of the horizontal motor, calculates the length of the spine of the human body based on the measured operating current, and precisely determines the positions of the cervical vertebrae, the thoracic vertebrae, the lumbar vertebrae, and the coccyx that form the spine. As a result, acupuncture points suitable for a specific person are calculated and then the calculated acupuncture points are enabled to be used to administer thermotherapy.

Abstract: Provided are a neural electrode for measuring a neural signal, and a method for manufacturing the same. The method for manufacturing the same includes forming an ITO electrode on a substrate, forming a passivation layer for exposing a portion of the ITO electrode, forming ITO nanowires on the ITO electrode, and forming a metal oxide on the ITO nanowires.

Abstract: The present disclosure relates to: an adipocyte-targeting non-viral gene delivery complex comprising a sh(FABP4+FABP5) dual plasmid vector; and treatment for obesity and obesity-induced metabolic syndromes by using the same and, more particularly, to a gene delivery complex comprising: an adipocyte-targeting sequence; a nine-arginine (R9) peptide; and a dual plasmid vector comprising a gene for treatment of obesity and obesity-induced metabolic syndromes, wherein the gene for treatment of obesity and obesity-induced metabolic syndromes is a base sequence inhibiting the expression of a FABP4 gene and a FABP5 gene. According to the present disclosure, in order to treat obesity-related diseases, a dual plasmid vector capable of simultaneously inhibiting the FABP4 and FABP5 genes is produced, and this vector is bound to a predetermined delivery system that specifically delivers the vector into adipocytes so as to provide a gene delivery complex.

Abstract: The present invention relates to a visceral adipose tissue macrophage-targeted non-viral gene/carrier complex for preventing and treating obesity-induced type II diabetes. More specifically, the gene/carrier complex according to the present invention delivers a therapeutic gene in a stable manner in a case of being injected into the body with the visceral adipose tissue macrophages being targeted, and thus exhibits an excellent inhibitory effect against TACE, which allows the gene/carrier complex to be applied for prevention or treatment of obesity-induced type II diabetes.

Abstract: The present invention relates to a parenteral bioactive substance delivery composition and a bioactive substance carrier using a micelle based on low molecular weight methyl cellulose with a weight average molecular weight of 6 to 9.5 kDa. The low molecular weight methyl cellulose with a weight average molecular weight of 6 to 9.5 kDa resolves a problem of excretion to outside of the body to improve safety and form a micelle to solubilize poorly soluble bioactive substances, and thus is very useful for sustained release parenteral bioactive substance delivery.

Abstract: Provided is an electrode assembly which may be manufactured by providing a first substrate and a second substrate, plasma treating the first substrate, forming an electrode on the first substrate, and thermally compressing the first substrate and the second substrate, with the electrode therebetween, wherein each of the first substrate and the second substrate includes a fluorine-based polymer.

Abstract: The present invention relates to a method for setting a massage pattern of a thermotherapy device, and more specifically, to a method for setting a massage pattern, wherein the movement of a moxibustion device is patterned according to diseases so as to allow a bone of the spine associated with a disease to be intensively massaged, and thus if a disease is selected, a moxibustion device is operated by a motor according to the set massage pattern so as to enable an automatic customized massage according to the disease.

Abstract: An incombustible color-coated steel sheet for household appliances and building materials and a method for manufacturing the same, includes a flame-retardant coating composition that is a colored coating composition coated on a base steel sheet so that the coated steel sheet can have more than a certain level of flame-retardant properties and can also exhibit excellent physical properties, including processability, coating adhesion, corrosion resistance, and hardness.

Abstract: Provided are a neural electrode for measuring a neural signal, and a method for manufacturing the same. The method for manufacturing the same includes forming an ITO electrode on a substrate, forming a passivation layer for exposing a portion of the ITO electrode, forming ITO nanowires on the ITO electrode, and forming a metal oxide on the ITO nanowires.

Abstract: Disclosed is a gene/carrier complex for preventing or treating inflammatory diseases, including tumor necrosis factor-? converting enzyme (TNF-? converting enzyme, TACE) shRNA and a nonviral gene carrier, wherein the nonviral gene carrier includes an acetate of disulfide-linked poly(oligo-arginine) or a TFA salt of poly(oligo-aspartic acid)poly(oligo-arginine).